RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.93B
AUM Growth
+$243M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$95M
2
+$77.3M
3
+$72.9M
4
PCVX icon
Vaxcyte
PCVX
+$61.2M
5
ACRV icon
Acrivon Therapeutics
ACRV
+$55.4M

Top Sells

1
+$180M
2
+$112M
3
+$74.6M
4
RLMD icon
Relmada Therapeutics
RLMD
+$74M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.5M

Sector Composition

1 Healthcare 99.36%
2 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$850M 17.23%
6,957,179
-610,721
2
$281M 5.7%
5,857,459
+1,276,256
3
$242M 4.91%
236,114
4
$214M 4.33%
6,848,911
+1,640,000
5
$165M 3.35%
6,317,990
+267,990
6
$161M 3.26%
5,516,067
+45,000
7
$152M 3.07%
7,040,622
8
$151M 3.07%
22,748,880
+11,627,907
9
$148M 2.99%
532,892
-404,657
10
$137M 2.77%
13,381,054
11
$122M 2.47%
2,436,223
+97,613
12
$121M 2.45%
5,454,533
+3,287,142
13
$120M 2.44%
17,202,009
14
$114M 2.32%
8,670,644
15
$114M 2.31%
8,955,410
+1,172,741
16
$109M 2.21%
8,131,952
17
$108M 2.2%
21,853,958
+112,500
18
$102M 2.08%
12,452,574
+1,067,000
19
$95M 1.93%
+3,853,867
20
$92.5M 1.88%
2,075,000
21
$86.3M 1.75%
4,417,259
22
$83.8M 1.7%
3,984,681
-938,260
23
$69.4M 1.41%
5,999,481
+1,986,028
24
$69.3M 1.41%
4,398,453
25
$69.2M 1.4%
9,505,925
+2,505,925
1
2 3 4